Skip to Content

EvaMist Approval History

  • FDA approved: Yes (First approved July 27th, 2007)
  • Brand name: EvaMist
  • Generic name: estradiol
  • Dosage form: Transdermal Spray
  • Company: VIVUS, Inc.
  • Treatment for: Postmenopausal Symptoms

EvaMist is an estradiol transdermal spray administered once daily for the treatment of vasomotor symptoms (hot flashes) associated with menopause.

Development History and FDA Approval Process for EvaMist

Jul 30, 2007Approval KV Pharmaceutical Announces U.S. Food and Drug Administration Approval of EvaMist
Dec 12, 2006VIVUS Announces FDA Acceptance of EvaMist NDA Submission
Oct  2, 2006VIVUS Submits New Drug Application With U.S. Food and Drug Administration for EvaMist

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.